Read the Latest Stories from PressRelease.com
Browse the daily collection of news, information and press releases from around the world
Browse the daily collection of news, information and press releases from around the world
Duane Boise CEO MMJ International Holdings stated "You cannot shortcut the FDA. Many companies are just now deciding they want to be pharmaceutical, but the real barrier to entry is time spent inside the regulatory process. MMJ International Holdings made that commitment nearly a decade ago, and that investment in science and compliance is now proving to be our greatest strategic advantage."
Read More
Attendees can use onsite Black Book trophies to quickly identify exhibitors from over 1000 booths that earned standout user satisfaction marks in Black Book's Q3 2025 through Q1 2026 polling cycle
Read More
"Schedule III doesn't lift all boats; it separates medicine from merchandise," said Duane Boise, President & CEO of MMJ International Holdings. "This realignment is about allowing science to operate within a federally coherent structure. MMJ was built specifically for this architecture. We built real medicine while others built storefronts."
Read More
After a challenging 2025 marked by political uncertainty and the impact of tariffs, German companies in the U.S. are anticipating a rebound in 2026.
Sales Development: 82% of German companies in the U.S. expect sales growth in 2026, after 64% saw growth and 23% experienced a decline in 2025.
Challenges: Political uncertainty (46%) and the financial impact of tariffs (44%) replace shortage of skilled workers as top challenges for German companies in the U.S.
Tariffs: 86% of the respondents report negative impacts from U.S. tariff policies, while 31% saw positive effects from tariffs.
Investment: 67% plan to increase their U.S. investments in 2026; 56% intend to invest at least over 1 million USD over the next three years. Workforce development and digital transformation are the top investment priorities.
AI: 57% of companies have already implemented AI projects - more than twice as many as in the previous year (28%).
Correction removes incorrect date in headline
Read More
After a challenging 2025 marked by political uncertainty and the impact of tariffs, German companies in the U.S. are anticipating a rebound in 2026.
Sales Development: 82% of German companies in the U.S. expect sales growth in 2026, after 64% saw growth and 23% experienced a decline in 2025.
Challenges: Political uncertainty (46%) and the financial impact of tariffs (44%) replace shortage of skilled workers as top challenges for German companies in the U.S.
Tariffs: 86% of the respondents report negative impacts from U.S. tariff policies, while 31% saw positive effects from tariffs.
Investment: 67% plan to increase their U.S. investments in 2026; 56% intend to invest at least over 1 million USD over the next three years. Workforce development and digital transformation are the top investment priorities.
AI: 57% of companies have already implemented AI projects - more than twice as many as in the previous year (28%).
American Rebel Light Patriotic Beer Garden Anchors the Midway + CEO Andy Ross Brings Live Music Between Nitro Rounds on the American Rebel Stage
American Rebel Racing 2026 NHRA Sponsorship: TSR's Leah Pruett - Nitro Top Fuel and Matt Hagan Nitro Funny Car, and Pro Stock Motorcycle Driver John Hall make 2026 season debut
Orders for Ondas' Sentrycs Counter-UAS Systems Reflect Growing Demand to Protect Critical Infrastructure and Strategic Facilities Amid Ongoing Regional Conflicts
Immediate Urgent Deployment of Ondas' Systems Support Defense, Homeland Security, and Infrastructure Protection Programs Across the Middle East and other regions
Read More
Experienced Hospitality Executive and Founder of Successful Luxury and Lifestyle Brand Aligns with NextTrip to Advance Premium Wellness, Experiential Travel, and Media-to-Commerce Initiatives
Read More
Ladan Hosseinzadeh Sadeghi, President & CEO of Sky Property Group Inc., calls on developers, governments, and investors to accelerate the adoption of modular and prefabricated construction to address Canada's deepening housing shortage.
Read More
"For too long, legitimate cannabinoid medicine has been trapped between two federal systems that were never designed to work together," said Duane Boise, CEO of MMJ International Holdings. "The FDA encourages clinical research into cannabinoids, yet companies pursuing those trials have faced extraordinary obstacles obtaining the pharmaceutical-grade materials required to conduct them. If the United States is serious about developing cannabinoid medicines, the regulatory framework must support science rather than obstruct it."
Read More